Table 2.
Baseline Lipids and Lipoproteins Values of 351 RTRs.
| Variables | Total | Incident PTDM | p Value | |
|---|---|---|---|---|
| Yes | No | |||
| Participants, n | 351 | 39 | 312 | |
| Triglycerides (total), mg/dL | 149 (103–208) | 173 (126–297) | 146 (102–200) | 0.004 |
| Total cholesterol, mg/dL | 198.9 ± 41.0 | 295.1 ± 45.8 | 198.1 ± 40.3 | 0.365 |
| HDL cholesterol (total), mg/dL | 54.4 ± 14.8 | 48.4 ± 10.6 | 55.2 ± 15.1 | 0.001 |
| TRL particles (total), nmol/L | 189 (138–265) | 219 (148–316) | 184 (136–263) | 0.068 |
| LDL particles (total), nmol/L | 1400 (1171–1632) | 1427 (1335–1673) | 1395 (1158–1622) | 0.212 |
| HDL particles (total), µmol/L | 20.5 ± 3.3 | 20.1 ± 3.2 | 20.5 ± 3.3 | 0.469 |
| Large HDL particles, µmol/L | 2.2 (1.3–3.6) | 1.4 (1.0–2.3) | 2.3 (1.4–3.8) | <0.001 |
| Medium HDL particles, µmol/L | 4.9 ± 2.1 | 4.6 ± 1.9 | 4.9 ± 2.2 | 0.452 |
| Small HDL particles, µmol/L | 13.0 ± 3.3 | 13.8 ± 2.9 | 12.9 ± 3.3 | 0.095 |
| HDL size, nm | 9.1 ± 0.5 | 8.9 ± 0.3 | 9.2 ± 0.5 | 0.001 |
| HDL Subspecies | ||||
| H7P, µmol/L | 0.3 (0.1–0.5) | 0.2 (0.1–0.3) | 0.3 (0.1–0.6) | 0.022 |
| H6P, µmol/L | 0.6 (0.2–1.5) | 0.3 (0.1–0.7) | 0.7 (0.2–1.6) | 0.002 |
| H5P, µmol/L | 0.9 (0.4–1.5) | 0.8 (0.4–1.2) | 0.9 (0.4–1.5) | 0.378 |
| H4P, µmol/L | 1.7 (1.1–2.5) | 1.7 (1.3–2.4) | 1.7 (1.1–2.5) | 0.841 |
| H3P, µmol/L | 2.8 (1.5–4.2) | 2.9 (1.4–4.3) | 2.8 (1.5–4.2) | 0.768 |
| H2P, µmol/L | 9.6 (7.6–11.8) | 11.0 (8.8–12.5) | 9.4 (7.4–11.6) | 0.024 |
| H1P, µmol/L | 3.0 (1.8–4.5) | 3.0 (1.5–4.1) | 3.0 (1.8–4.7) | 0.569 |
Data are the mean ± SD, median (interquartile range) unless otherwise indicated. Significance was tested by t-tests and Wilcoxon tests for normal distribution and skewed distribution of continuous values respectively. HDL: high-density lipoprotein; TRL: triglyceride-rich lipoprotein; LDL: low-density lipoprotein.